StepStone Private Wealth Launches Private Credit Fund
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) — StepStone Private Wealth (“SPW”) today announced the launch of the StepStone Private […]
From Rodeo Drive to Malibu Beaches: Luxury Land Rover Defender and Beach Runner Define Sophisticated Living
KISSIMMEE, Fla., June 06, 2024 (GLOBE NEWSWIRE) — ECD Auto Design, is thrilled to have toured the west coast from […]
Itron Collaborates with VODA.ai to Pinpoint Water Pipe Failure with Artificial Intelligence
LIBERTY LAKE, Wash. and BOSTON, June 06, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways […]
Safety Shot Partners with Capital Drugs To Launch World’s First Beverage To Reduce Blood Alcohol Content in 300 Pharmacies Across the Country
The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide JUPITER, FL, June 06, […]
Mama’s Creations to Expand Offering with Multiple New Products and Flavors at IDDBA 2024
Breakfast Wraps, Grilled Chicken Breast in Vacuum Packs, Meatball Entertaining Sleeves, and Paninis to Launch at Industry’s Most Significant Event […]
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical […]
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
Bridgeline Announces New GenAI Features in Latest HawkSearch Update
WOBURN, Mass., June 06, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, […]
SurgePays, Inc. Announces Launch of Prepaid Wireless Brand LinkUp Mobile
BARTLETT, Tenn., June 06, 2024 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG) (“SurgePays” or the “Company”), a technology and telecom […]
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
Company expects to lock database in June andremains on track to report key outcomes later in July. Pepinemab targets astrocyte […]
